HER2/neu癌基因及其产物测定在乳腺癌的临床应用
被引量:2
出处
《中原医刊》
2006年第11期57-59,共3页
Central Plains Medical Journal
基金
河南省省属科研院所研究专项资金(0441130401)
参考文献26
-
1Singleton TP,Strickler JG.Clinical and pathologic significance of the c-erbB -2 (HER-2/neu) oncogene.Pathol Annu,1992,27:165 ~190.
-
2Harari D,Yarden Y.Molecular mechanisms underlying ErbB2/HER2action in breast cancer.Oncogene,2000,19 (53):6102 ~ 6114.
-
3Zabrecky JR,Lam T,McKenzie SJ,et al.The extracellular domain of p185/c -erbB -2 is released from the surface of human breast carcinoma cells,SK-BR-3.J Biol Chem,1991,266:1716~1720.
-
4Carney WP,Hamer PJ,Petit D,et al.Detection and quantitation of the human neu oncoprotein.J Tumor Marker Oncol,1991,6:53 ~72.
-
5Cook GB,Neaman IE,Goldblatt.JL,et al.Clinical utility of serum Her-2/neu testing on the Bayer Immuno 1 automated system in breast cancer.Anticancer Res,2001,21 (2B):1465 ~ 1470.
-
6Slamon DJ,Clark GM,Wong SG,et al.Human breast cancer:correlation of relapse and survival with amplification of the Her-2/neu oncogene.Science,1987,235:177~182.
-
7Slamon DJ,Godolphin W,Jones LA,et al.Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.Science,1989,244:707~712.
-
8Press MF,Bernstein L,Thomas PA,et al.Her -2/neu gene amplification characterized by fluorescence in situ hybridization:poor prognosis innode-negative breast carcinomas.J Clin Oncol,1997,15:2894~2904.
-
9Sjogren S,Inganas M,Lindgren A,et al.Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer,alone and in combination withother prognostic markers.J Clin Oncol,1998,16:462~469.
-
10Allred DC,Clark GM,Tandon AK,et al.Her-2/neu in node-negative breast cancer:prognostic significance of overexpression influenced by the presence of in situ carcinoma.J Clin Oncol,1992,10:599 ~605.
二级参考文献7
-
1孙燕.乳腺癌的内科治疗现代诊断与治疗[M].北京:北京医科大学和中国协和医科大学联合出版社,1988,9.193-196.
-
2Baselga J, Tripathy D, Mendelsohn J, et al, Phase II study of weekly intravenous recombiTmnt humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. JClin Oncol, 1996, 14: 737-744.
-
3Vogel CL, Cobleigh MA, Tripalhy D, et al. First-line herceptin monolherapy in metastatic breast cancer. Oncology 2001,61 ( Suppl2).37-42.
-
4Fomier M, Esteva FJ, Seidman AD. Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer. Semin-Oncol,2000, 27: 38-45.
-
5Baselga J, Norton L, Albanell J, et al. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res, 1998, 58: 2825-2831.
-
6周爱萍,冯奉仪.乳腺癌靶向治疗:Herceptin的研究进展[J].国外医学(肿瘤学分册),2000,27(3):167-170. 被引量:18
-
7宋海珠.Herceptin治疗转移性乳腺癌的研究进展[J].中国肿瘤生物治疗杂志,2002,9(2):144-145. 被引量:14
共引文献16
-
1白璃,赵瑛.HER-2与乳腺癌[J].基层医学论坛,2008,12(28):933-935. 被引量:1
-
2罗荣城,曹梦苒.乳腺癌分子靶向治疗与生物化疗[J].癌症进展,2004,2(5):370-373. 被引量:7
-
3周鑫,孙治君.乳腺癌中基因表达对化疗疗效的预测[J].重庆医学,2005,34(3):453-456. 被引量:2
-
4李爱华,靳卫国,王伟华,刘薇,任玉波,周宏,孔爱荣.Herceptin及联合顺铂对高表达HER-2/neu卵巢癌体外作用的实验研究及机制探讨[J].中华医学杂志,2005,85(44):3158-3160. 被引量:1
-
5华彬,韦军民.乳癌HER-2基因研究的进展与现状[J].中国医刊,2006,41(1):46-48. 被引量:5
-
6李爱华,靳卫国,刘薇,任玉波,周宏,孔爱荣.Herceptin联合顺铂对高表达HER-2/neu卵巢癌移植瘤鼠的治疗作用[J].中国肿瘤生物治疗杂志,2006,13(1):50-53. 被引量:1
-
7郑媛媛.肿瘤的单抗靶向疗法在国内的研究和应用进展[J].中国肿瘤生物治疗杂志,2006,13(1):70-72. 被引量:2
-
8李爱华,靳卫国,刘薇,周宏,田春,袁彤.Herceptin联合顺铂对高表达Her-2/neu卵巢癌体外作用的实验研究[J].肿瘤研究与临床,2006,18(5):298-300. 被引量:2
-
9刘彩云,杨蔚,李金锋,孙素莲,寿成超.曲妥珠单抗对HER-2胞外域水平不同的肿瘤细胞系的影响[J].中华肿瘤杂志,2007,29(2):101-105. 被引量:1
-
10乔杉杉,王大业.乳腺癌HER2基因的研究进展及其靶点治疗[J].首都医科大学学报,2008,29(1):96-99. 被引量:11
同被引文献21
-
1申良方,张阳德.PEI-Fe_3O_4纳米粒E1A基因对人宫颈癌细胞周期的影响[J].中国现代医学杂志,2005,15(12):1771-1773. 被引量:7
-
2姜超,张峰,王少军,邹奇飞.COX-2与HIF-1α在肝癌中的表达与相关性[J].中国普外基础与临床杂志,2006,13(2):142-144. 被引量:6
-
3周际昌主编.实用肿瘤内科学.北京:人民卫生出版社,2005:45-48.
-
4Rong-Rong Zhou, Shu-Fang Jia, Zhichao Zhou, et al. Adenovirus-E1A gene therapy enhance the in vivo sensitivity of Ewings sarcoma to VP-16. Cancer Gene Therapy ,2002, 9:407-413.
-
5Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A labomtory Mamral, 2nd ed . New York; Cold Spring harbor laboratory Press, 1989:456-468.
-
6Yu D, MATIN A, XIA W, et al. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu, Oncogene, 1995,11 (7) : 1383-1388.
-
7CHINNADURAIG, Adenovirus E1A as a tumor suppressor or gene Oncogene, 1992,7 : 1255-1258.
-
8Zaslaweki R,Surowiak P,Paluchowski P,et al.Differences in oest-rigen and progesterone receptors,HER-2,p53expression and prolifer-ation in ductal breast cancers in relation to histopathological grade[].Folia Morphologica.2005
-
9Dannenberg A J,Altorki N K,Boyle J O,et al.Cyclooxygenase-2: a pharmacological target fox the prevention of cancer[].Lancet OncologyThe.2001
-
10Soslow RA,Dannenberg AJ,Rush D,et al.COX-2 is expressed in human pulmonary, colonic and mammary rumors[].Cancer.2000
引证文献2
-
1肖华平,廖遇平,周蓉蓉,申良方,姜武忠,伍海军.E1A基因对人乳腺癌细胞化疗药物敏感性的影响[J].中国医师杂志,2007,9(10):1361-1363. 被引量:1
-
2赵永庆,张富喜,曹巍子.乳腺癌COX-2表达及其与ER、PR、C-erbB-2的相关性[J].医学信息(手术学分册),2008,21(7):629-632. 被引量:2
二级引证文献3
-
1肖华平,周蓉蓉,廖遇平.E1A抑制鼻咽癌细胞裸鼠移植瘤的生长并增强其对放疗的敏感性[J].中国肿瘤生物治疗杂志,2009,16(6):614-618. 被引量:3
-
2宁宇,邹三鹏,章志福,刘倩平,魏涛,陈维.塞来昔布对ER、PR阴性表达乳腺癌的临床疗效研究[J].肿瘤药学,2013,3(3):192-195. 被引量:2
-
3韩珊莉.乳腺癌患者人表皮生长因子受体-2表达与雌激素受体孕激素受体的关系[J].山西医药杂志,2014,43(15):1807-1808. 被引量:2
-
1李广太,焦书竹.卵巢癌neu癌基因的研究进展[J].中华妇产科杂志,1995,30(3):176-179. 被引量:3
-
2桂开林.NEU癌基因的研究进展[J].国外医学(生理病理科学与临床分册),1993,13(1):9-11. 被引量:1
-
3王相如.HER2/neu癌基因在骨肉瘤和骨骼尤文氏肉瘤中表达缺失[J].医学信息(医学与计算机应用),2002,15(9):550-550.
-
4崔文,孔霞,张波.甲状腺癌Neu癌基因表达的研究[J].山东医药,2000,40(20):12-14. 被引量:1
-
5邓志宏,黄维国,金岩.c-myc与c-neu癌基因在头颈部鳞状上皮癌旁组织及癌变中的表达及相互关系[J].耳鼻咽喉(头颈外科),1997,4(2):97-101. 被引量:3
-
6崔文,高继发,王旭,任启伟,孔灵玲,成磊.neu癌基因在人类甲状腺癌中表达的研究[J].济宁医学院学报,2003,26(1):1-3. 被引量:1
-
7赵惠柳,黄玲莎,朱波.CYFRA21-1、CA153联合检测对乳腺癌的诊断意义[J].海南医学,2005,16(12):143-144. 被引量:6
-
8张雯.口服避孕药与乳腺痛发病率的关系[J].国外医学(计划生育分册),2003,22(3):186-186.
-
9汪宝琮,何家玉,汪荣法.11例男性乳腺痛临床病理分析[J].皖南医学院学报,1991,10(4):246-247.
-
10李凤中,陈波,夏洪娇.miR-19影响人乳腺癌MCF7细胞增殖、迁移及侵袭的研究[J].中国现代医生,2013,51(30):40-41.